UNM

UNM Interest Expense

$211.20MTTM · USD

Period ending:

UNM FY Interest ExpenseUSD
UNM FY Interest Expense1985-12-31: $0.001986-12-31: $0.001987-12-31: $0.001988-12-31: $0.001989-12-31: $357.60M1990-12-31: $355.60M1991-12-31: $365.90M1992-12-31: $335.60M1993-12-31: $293.70M1994-12-31: $261.40M1995-12-31: $264.60M1996-12-31: $241.30M1997-12-31: $84.90M1998-12-31: $119.90M1999-12-31: $137.80M2000-12-31: $181.80M2001-12-31: $169.60M2002-12-31: $162.40M2003-12-31: $187.20M2004-12-31: $207.10M2005-12-31: $208.00M2006-12-31: $191.80M2007-12-31: $241.90M2008-12-31: $156.70M2009-12-31: $125.40M2010-12-31: $141.80M2011-12-31: $143.30M2012-12-31: $145.40M2013-12-31: $149.40M2014-12-31: $167.50M2015-12-31: $152.80M2016-12-31: $166.00M2017-12-31: $159.90M2018-12-31: $167.30M2019-12-31: $177.40M2020-12-31: $188.20M2021-12-31: $185.00M2022-12-31: $188.50M2023-12-31: $194.80M2024-12-31: $201.10M2025-12-31: $208.80M$365.90M$0.00
1985-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

UNM interest expense history

Interest expense on outstanding debt. The available annual fiscal periods series contains 41 observations from Dec 31, 1985 to Dec 31, 2025.

Unum Group Common Stock Interest Expense — Annual fiscal periods (USD)
Period endingInterest Expense (USD)
208,800,000
201,100,000
194,800,000
188,500,000
185,000,000
188,200,000
177,400,000
167,300,000
159,900,000
166,000,000
152,800,000
167,500,000
149,400,000
145,400,000
143,300,000
141,800,000
125,400,000
156,700,000
241,900,000
191,800,000
208,000,000
207,100,000
187,200,000
162,400,000
169,600,000
181,800,000
137,800,000
119,900,000
84,900,000
241,300,000
264,600,000
261,400,000
293,700,000
335,600,000
365,900,000
355,600,000
357,600,000
0
0
0
0

Compare interest expense

All UNM financial metrics · UNM stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.